Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial oxidative phosphorylation (OXPHOS) system is the primary energy-generating machinery in eukaryotic cells, consisting of five multi-subunit protein complexes (Complexes I-V) located in the inner mitochondrial membrane (StatPearls, 2023). It couples the transfer of electrons from electron donors (NADH and FADH2) to oxygen with the pumping of protons to create an electrochemical gradient, which ultimately drives the synthesis of ATP by ATP synthase (NCBI, 2022). Beyond energy production, this machinery plays critical roles in regulating cellular redox state, reactive oxygen species (ROS) signaling, and the initiation of apoptosis (Nature Reviews Molecular Cell Biology, 2020). Dysregulation of OXPHOS is implicated in a wide range of pathologies, including primary mitochondrial disorders, neurodegenerative diseases like Parkinson's, and metabolic syndromes (PubMed, 2021). In oncology, certain cancers exhibit a high dependency on OXPHOS, making specific components like Complex I attractive therapeutic targets for small-molecule inhibitors such as IACS-010759 (Nature Medicine, 2018). However, targeting these enzymes requires careful management of systemic toxicity, as they are essential for the function of high-energy-demand organs like the heart and brain (Journal of Clinical Investigation, 2017).
Inhibition of electron transport chain complexes (I-IV), uncoupling of oxidative phosphorylation, and inhibition of ATP synthase (Complex V) to modulate cellular energy levels and redox state.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial oxidative phosphorylation system (OXPHOS) (OXPHOS).